Navigating Acute Myeloid Leukemia Treatment: Therapy-Related & De Novo AML with Dr. Naval Daver
Автор: OncBrothers: Practice-Changing Cancer Discussions
Загружено: 2026-02-02
Просмотров: 64
Описание:
In this episode of the Oncology Brothers podcast, we discussed two challenging cases focused on Acute Myeloid Leukemia (AML). We welcomed Dr. Naval Daver, a leading expert from MD Anderson Cancer Center, to discuss: therapy-related AML and de novo AML where induction chemotherapy is not an option.
Episode Highlights:
• Overview of therapy-related AML and its increasing prevalence due to advancements in solid tumor treatments.
• In-depth discussion on the prognosis and treatment options for patients with complex cytogenetics.
• Comparison of induction treatments: CPX-351 vs. the traditional 7 + 3 regimen, including survival rates and side effects.
• Insights into the use of hypomethylating agents combined with venetoclax for older patients with AML, particularly those with NPM1 mutations.
• Practical considerations for administering these treatments in both inpatient and outpatient settings.
Whether you're a healthcare professional or simply interested in the latest advancements in oncology, this episode provides valuable insights into the complexities of AML management.
Follow us on social media:
• X/Twitter: / oncbrothers
• Instagram: / oncbrothers
• Website: https://oncbrothers.com/
Don't forget to subscribe for more discussions on treatment algorithms, conference highlights, and the latest FDA approvals!
#AcuteMyeloidLeukemia, #TherapyRelatedAML, #DeNovoAML, #TransplantIneligible, #OncologyBrothers
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
